Nuvation Bio, Inc. (NUVB)
5.14
-0.42
(-7.55%)
USD |
NYSE |
Oct 02, 16:00
5.17
+0.03
(+0.58%)
Pre-Market: 20:00
Nuvation Bio Total Assets (Quarterly) : 744.50M for June 30, 2026
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 744.50M |
| March 31, 2026 | 610.24M |
| December 31, 2025 | 594.82M |
| September 30, 2025 | 601.56M |
| June 30, 2025 | 647.22M |
| March 31, 2025 | 492.49M |
| December 31, 2024 | 540.63M |
| September 30, 2024 | 571.58M |
| June 30, 2024 | 594.80M |
| March 31, 2024 | 613.12M |
| December 31, 2023 | 621.48M |
| September 30, 2023 | 630.87M |
| June 30, 2023 | 641.41M |
| Date | Value |
|---|---|
| March 31, 2023 | 657.06M |
| December 31, 2022 | 672.14M |
| September 30, 2022 | 686.49M |
| June 30, 2022 | 719.74M |
| March 31, 2022 | 751.80M |
| December 31, 2021 | 776.15M |
| September 30, 2021 | 797.79M |
| June 30, 2021 | 814.26M |
| March 31, 2021 | 832.06M |
| December 31, 2020 | 221.79M |
| September 30, 2020 | 145.50M |
| June 30, 2020 | 0.1711M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Bristol Myers Squibb Co. | 87.63B |
| Johnson & Johnson | 201.06B |
| Pfizer Inc. | 201.13B |
| Eli Lilly & Co. | 142.28B |
| Merck & Co., Inc. | 129.80B |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 490.64M |
| Shareholders Equity (Quarterly) | 253.86M |
| Debt to Equity Ratio | 1.640 |
| Current Ratio | 8.373 |
| Net Debt Paydown Yield | -4.08% |